Insulin lispro low mixture twice daily vs basal insulin glargine once daily and prandial insulin lispro once daily as insulin intensification strategies in patients with type 2 diabetes: Latin American subpopulation analysis of a randomized trial

BACKGROUND: This post hoc analysis examined the efficacy and safety of twice-daily insulin lispro low mixture (LM25) and once-daily basal insulin glargine plus once-daily prandial insulin lispro (IGL) in a Latin American subpopulation with type 2 diabetes mellitus (T2DM). METHODS: A phase 4, randomi...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Diabetol Metab Syndr
Asıl Yazarlar: Rojas, Arturo, Sposetti, Georgina, Gross, Jorge L., Barbieri, Douglas Eugenio, Duan, Ran, Linetzky, Bruno, De Lana, Janaina Martins, Stempa, Oded, Rodriguez, Angel
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: BioMed Central 2016
Konular:
Research
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5027076/
https://ncbi.nlm.nih.gov/pubmed/27660663
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13098-016-0163-3
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller